How can we find that sweet spot between patient-centricity and profitability - the modern pharma company is constantly faced with this dilemma? While patient-centricity first took root in the R&D side of the business. Its tendrils have now extended
How can we find that sweet spot between patient-centricity and profitability - the modern pharma company is constantly faced with this dilemma? While patient-centricity first took root in the R&D side of the business. Its tendrils have now extended
